TY - JOUR
T1 - Considerations for refining the risk assessment process for formaldehyde
T2 - Results from an interdisciplinary workshop
AU - Andersen, Melvin E.
AU - Gentry, P. Robinan
AU - Swenberg, James A.
AU - Mundt, Kenneth A.
AU - White, Kimberly W.
AU - Thompson, Chad
AU - Bus, James
AU - Sherman, James H.
AU - Greim, Helmut
AU - Bolt, Hermann
AU - Marsh, Gary M.
AU - Checkoway, Harvey
AU - Coggon, David
AU - Clewell, Harvey J.
N1 - Publisher Copyright:
© 2019 The Authors
PY - 2019/8
Y1 - 2019/8
N2 - Anticipating the need to evaluate and integrate scientific evidence to inform new risk assessments or to update existing risk assessments, the Formaldehyde Panel of the American Chemistry Council (ACC), in collaboration with the University of North Carolina, convened a workshop: “Understanding Potential Human Health Cancer Risk - From Data Integration to Risk Evaluation” in October 2017. Twenty-four (24)invited-experts participated with expertise in epidemiology, toxicology, science integration and risk evaluation. Including members of the organizing committee, there were 29 participants. The meeting included eleven presentations encompassing an introduction and three sessions: (1)“integrating the formaldehyde science on nasal/nasopharyngeal carcinogenicity and potential for causality”; (2)“integrating the formaldehyde science on lymphohematopoietic cancer and potential for causality; and, (3)“formaldehyde research-data suitable for risk assessment”. Here we describe key points from the presentations on epidemiology, toxicology and mechanistic studies that should inform decisions about the potential carcinogenicity of formaldehyde in humans and the discussions about approaches for structuring an integrated, comprehensive risk assessment for formaldehyde. We also note challenges expected when attempting to reconcile divergent results observed from research conducted within and across different scientific disciplines - especially toxicology and epidemiology - and in integrating diverse, multi-disciplinary mechanistic evidence.
AB - Anticipating the need to evaluate and integrate scientific evidence to inform new risk assessments or to update existing risk assessments, the Formaldehyde Panel of the American Chemistry Council (ACC), in collaboration with the University of North Carolina, convened a workshop: “Understanding Potential Human Health Cancer Risk - From Data Integration to Risk Evaluation” in October 2017. Twenty-four (24)invited-experts participated with expertise in epidemiology, toxicology, science integration and risk evaluation. Including members of the organizing committee, there were 29 participants. The meeting included eleven presentations encompassing an introduction and three sessions: (1)“integrating the formaldehyde science on nasal/nasopharyngeal carcinogenicity and potential for causality”; (2)“integrating the formaldehyde science on lymphohematopoietic cancer and potential for causality; and, (3)“formaldehyde research-data suitable for risk assessment”. Here we describe key points from the presentations on epidemiology, toxicology and mechanistic studies that should inform decisions about the potential carcinogenicity of formaldehyde in humans and the discussions about approaches for structuring an integrated, comprehensive risk assessment for formaldehyde. We also note challenges expected when attempting to reconcile divergent results observed from research conducted within and across different scientific disciplines - especially toxicology and epidemiology - and in integrating diverse, multi-disciplinary mechanistic evidence.
KW - Evidence integration
KW - Formaldehyde
KW - Inconsistent human epidemiology
KW - Integrating data streams
KW - Mode-of-action in animal studies
KW - Reconciling conflicting conclusions
UR - http://www.scopus.com/inward/record.url?scp=85065573461&partnerID=8YFLogxK
U2 - 10.1016/j.yrtph.2019.04.015
DO - 10.1016/j.yrtph.2019.04.015
M3 - Article
C2 - 31059732
AN - SCOPUS:85065573461
SN - 0273-2300
VL - 106
SP - 210
EP - 223
JO - Regulatory Toxicology and Pharmacology
JF - Regulatory Toxicology and Pharmacology
ER -